NCT02062619

Brief Summary

Central alexia is a common reading disorder caused by stroke. Patients with central alexia (CA) are slow to read and make frequent errors, and have additional problems with their spoken language. This study has 3 aims:

  1. 1.Investigating the neural networks that support reading in patients with CA Despite being a relatively common syndrome, there have been no functional brain imaging studies of CA. This project will use magnetic resonance imaging (MRI) and magnetoencephalography (MEG) to understand which brain regions are damaged and whether preserved parts of the reading network can be encouraged by therapy to support reading recovery.
  2. 2.Testing a new treatment for CA The research team has developed training software called 'iReadMore', which uses a crossmodal approach (written words paired with spoken words) to train reading. This therapy has been shown to be effective in patients with a similar form of reading disorder called pure alexia. The iReadMore software will be adapted to address the reading deficit in CA, and the research will test whether it significantly improves reading ability.
  3. 3.Using brain stimulation to enhance behavioural training Transcranial direct current stimulation (tDCS) is a brain stimulation technique that has been shown to improve language performance in healthy controls and stroke patients. This study will test whether tDCS (delivered simultaneously with the 'iReadMore' therapy) significantly enhances reading rehabilitation. Patients will be split into two groups: one will receive a 4 week block of training plus real tDCS first, followed by a 4 week block of training plus sham tDCS; the other group will receive the two therapy blocks in the opposite order. Both groups will ultimately receive the same amount of behavioural therapy and tDCS stimulation. Comparing the reading improvement over the real and sham tDCS blocks will demonstrate whether tDCS enhances the behavioural improvements in reading ability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Mar 2014

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 13, 2014

Completed
16 days until next milestone

Study Start

First participant enrolled

March 1, 2014

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

November 4, 2016

Status Verified

April 1, 2016

Enrollment Period

2.3 years

First QC Date

February 12, 2014

Last Update Submit

November 3, 2016

Conditions

Keywords

StrokeAphasiaAcquired reading disordersCentral alexiaComputer based rehabilitationTranscranial direct current stimulationtDCSMagnetoencephalographyMEGMagnetic Resonance ImagingMRI

Outcome Measures

Primary Outcomes (1)

  • Change in word reading speed and accuracy for trained and untrained words

    Word reading speed and accuracy will be assessed at multiple time-points: T1, T2: baseline assessments. T3: following 1 month no training. T4: following 1 month of iReadMore training with real / sham tDCS (crossover design). T5: following 1 month of iReadMore training with sham / real tDCS (crossover allocation reversed). T6: follow-up assessment after 3 months with no training. Planned comparisons: T3 vs \[average of T1 and T2\]: spontaneous improvement in reading ability T4 vs T3 / T5 vs T4: comparison of improvement following iReadMore with real/sham tDCS T6 vs T5: maintenance of therapy benefits at follow-up assessment.

    Baseline and up to 3 months follow-up

Secondary Outcomes (2)

  • Change in spoken word repetition for trained / untrained words

    Baseline and up to 3 months follow-up

  • Change in semantic word matching for trained / untrained words

    Baseline and up to 3 months follow-up

Other Outcomes (2)

  • Change in effective connectivity within the neural network involved in reading

    Baseline and up to 3 months follow-up

  • Change in grey matter or white matter volume

    Baseline and up to 3 months follow-up

Study Arms (2)

Real tDCS

EXPERIMENTAL

Transcranial direct current stimulation (tDCS) administered concurrently with computer-based behavioural word reading therapy. 2mA anodal direct current stimulation applied to the left inferior frontal gyrus (IFG) for first 20 minutes of therapy.

Behavioral: Computer-based behavioural word reading therapyOther: Real tDCS

Sham tDCS

SHAM COMPARATOR

Transcranial direct current stimulation (tDCS) administered concurrently with computer-based behavioural word reading therapy. Sham tDCS (periodical fade-in and fade-out stimulation routine) applied to the left inferior frontal gyrus (IFG) for first 20 minutes of therapy.

Behavioral: Computer-based behavioural word reading therapyOther: Sham tDCS

Interventions

Each patient participates in two blocks of reading training (one with real tDCS, one with sham tDCS). Different words will be trained in each training block. Each training block comprises 10 hours of reading therapy per week for four weeks (three 1-hour sessions/week at research site; 1-hour of training/day at home)

Real tDCSSham tDCS

Real tDCS 20 minutes per session, three times per week

Real tDCS

Sham tDCS, 20 minutes per session, 3 sessions per week

Sham tDCS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over 18 years old
  • Left hemisphere stroke or other focal brain injury
  • English as a first language
  • At least one year post stroke
  • Impaired reading ability (defined according to screening with the Comprehensive Aphasia Test, CAT)
  • Mild to moderate aphasia (defined according to screening with the CAT)
  • Competent to give informed consent

You may not qualify if:

  • Hemorrhagic stroke
  • History of significant premorbid neurological or psychiatric illness
  • History of developmental reading or speech and language disability
  • Severe speech production deficit (defined according to screening with the CAT)
  • Damage to tDCS target region (left inferior frontal gyrus)
  • Contraindications to MRI scanning (e.g. presence of ferromagnetic implants or other metallic or electronic objects in the body; weight over 24 stone; claustrophobia or pregnancy).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Neurology, University College London

London, WC1N 3AR, United Kingdom

Location

Related Publications (2)

  • Kerry SJ, Aguilar OM, Penny W, Crinion JT, Leff AP, Woodhead ZVJ. How Does iReadMore Therapy Change the Reading Network of Patients with Central Alexia? J Neurosci. 2019 Jul 17;39(29):5719-5727. doi: 10.1523/JNEUROSCI.1426-18.2019. Epub 2019 May 13.

  • Woodhead ZVJ, Kerry SJ, Aguilar OM, Ong YH, Hogan JS, Pappa K, Leff AP, Crinion JT. Randomized trial of iReadMore word reading training and brain stimulation in central alexia. Brain. 2018 Jul 1;141(7):2127-2141. doi: 10.1093/brain/awy138.

MeSH Terms

Conditions

StrokeBrain InjuriesAphasia

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesSpeech DisordersLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Alex Leff, MBBS, PhD

    University College, London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2014

First Posted

February 13, 2014

Study Start

March 1, 2014

Primary Completion

July 1, 2016

Study Completion

September 1, 2016

Last Updated

November 4, 2016

Record last verified: 2016-04

Locations